Switching from Aromatase Inhibitors to Dual Targeting Flavonoid-Based Compounds for Breast Cancer Treatment

Despite the significant outcomes attained by scientific research, breast cancer (BC) still represents the second leading cause of death in women. Estrogen receptor-positive (ER+) BC accounts for the majority of diagnosed BCs, highlighting the disruption of estrogenic signalling as target for first-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Gobbi, Silvia, Martini, Silvia, Rozza, Riccardo, Spinello, Angelo, Caciolla, Jessica, Rampa, Angela, Belluti, Federica, Zaffaroni, Nadia, Magistrato, Alessandra, Bisi, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096035/
https://www.ncbi.nlm.nih.gov/pubmed/37049810
http://dx.doi.org/10.3390/molecules28073047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096035/
https://www.ncbi.nlm.nih.gov/pubmed/37049810
http://dx.doi.org/10.3390/molecules28073047

Ejemplares similares